Furthermore, PLS3 was identified as negative prognostic marker in gastric cancer as patients with high PLS3 expression levels had a higher incidence of advanced tumor stage, cancer differentiation, tumor invasion depth, distant metastases and a significantly poorer prognosis than the low expression group. This evidence concerns the gene PLS3 and neoplasm.